ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,575.85
4.60%
S&P 500
5,640.50
0.45%
Dow Jones
40,286.01
0.71%
US Dollar vs Yen
157.8945
-0.27%
Brent Oil
84.325
-0.32%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Ritter Pharmaceuticals Inc (RTTR)

  7. Ritter Pharmaceuticals Inc (RTTR) ニュース

RTTR

Ritter Pharmaceuticals (RTTR)

Ritter Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:RTTR
日付受信時刻ニュースソース見出しコード企業名
2019/05/1508 : 57GlobeNewswire Inc.Ritter Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2019NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/05/0722 : 15GlobeNewswire Inc.Ritter Pharmaceuticals Completes Dosing of Last Patient in Pivotal 557-Subject Phase 3 Clinical Trial of RP-G28 in Patients w...NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/04/2619 : 23Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/04/2619 : 21Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/04/1221 : 30GlobeNewswire Inc.Analysis: Positioning to Benefit within Cemex S.A.B. de C.V, Strongbridge Biopharma, Overseas Shipholding Group, Ritter Pharm...NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/04/0119 : 28Edgar (US Regulatory)Annual Report (10-k)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/03/2922 : 26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/03/2922 : 00GlobeNewswire Inc.Ritter Pharmaceuticals Reports Year End 2018 Financial Results and Provides Business UpdateNASDAQ:RTTRRitter Pharmaceuticals Inc
2019/03/0621 : 02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/03/0522 : 30GlobeNewswire Inc.Ritter Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose IntoleranceNASDAQ:RTTRRitter Pharmaceuticals Inc
2019/02/2822 : 30GlobeNewswire Inc.Dr. William Chey Highlights Unmet Medical Need of Lactose Intolerance and Potential for Phase 3 Drug Candidate RP-G28 in Expe...NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/02/1503 : 33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/02/1406 : 34Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/02/1222 : 30GlobeNewswire Inc.Ritter Pharmaceuticals to Host Expert Call with Dr. William Chey on February 20, 2019NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/02/0906 : 30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/02/0906 : 25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/02/0906 : 22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/02/0906 : 20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/02/0906 : 16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/02/0906 : 13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/02/0906 : 07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/02/0905 : 58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/01/2322 : 30GlobeNewswire Inc.Ritter Pharmaceuticals To Present at Noble Capital Markets’ Fifteenth Annual Investor/Equity Conference on January 28, 2019...NASDAQ:RTTRRitter Pharmaceuticals Inc
2018/12/2907 : 03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RTTRRitter Pharmaceuticals Inc
2018/12/0422 : 30GlobeNewswire Inc.Ritter Pharmaceuticals Reaches Halfway Mark for Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lacto...NASDAQ:RTTRRitter Pharmaceuticals Inc
2018/12/0320 : 25Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:RTTRRitter Pharmaceuticals Inc
2018/12/0320 : 23Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:RTTRRitter Pharmaceuticals Inc
2018/11/2120 : 05Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:RTTRRitter Pharmaceuticals Inc
2018/11/0923 : 03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RTTRRitter Pharmaceuticals Inc
2018/11/0921 : 11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RTTRRitter Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:RTTR

最近閲覧した銘柄

AMEX
XLE
Energy Select Sector SPDR
CCOM
US500
US 500
FX
USDEUR
US Dollar vs Euro
NASDAQ
QQQ
Invesco QQQ Trust Series 1
FX
USDJPY
US Dollar vs Yen
NASDAQ
TSLA
Tesla
NASDAQ
AAPL
Apple
NYSE
JPM
JP Morgan Chase
NYSE
VZ
Verizon Communications
NYSE
BAC
Bank of America
NASDAQ
AMZN
Amazon.com
NYSE
NKE
Nike
USOTC
DTEGY
Deutsche Telekom (QX)
PM
XAUUSD
Gold vs US Dollar
NASDAQ
MSFT
Microsoft
AMEX
XLV
Health Care Select Sector
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有